ERBB2 and neoplasm: However, while most ER+ tumours are non-amplified for HER2, nearly 50% of all HER2 amplified tumours express ER at moderate to low concentrations [13,14], and recently, HER2 and ER have been shown to be positively correlated in HER2 non-amplified tumours [15].